We are live on ! Find out more
FG

Fairman Group Portfolio holdings

AUM $117M
1-Year Est. Return 5.24%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+5.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$124M
AUM Growth
+$2.6M
Cap. Flow
+$1.24M
Cap. Flow %
1%
Top 10 Hldgs %
69.52%
Holding
284
New
27
Increased
59
Reduced
25
Closed
10
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCK icon
226
Crown Holdings
CCK
$13.1B
$2.32K ﹤0.01%
24
FLJP icon
227
Franklin FTSE Japan ETF
FLJP
$3.66B
$2.32K ﹤0.01%
67
CNI icon
228
Canadian National Railway
CNI
$78.3B
$2.26K ﹤0.01%
24
CF icon
229
CF Industries
CF
$18.7B
$2.24K ﹤0.01%
25
TRN icon
230
Trinity Industries
TRN
$2.9B
$2.24K ﹤0.01%
80
EBAY icon
231
eBay
EBAY
$49.8B
$2K ﹤0.01%
22
MDT icon
232
Medtronic
MDT
$106B
$1.92K ﹤0.01%
20
UL icon
233
Unilever
UL
$134B
$1.54K ﹤0.01%
23
DEO icon
234
Diageo
DEO
$46.7B
$1.53K ﹤0.01%
16
PHO icon
235
Invesco Water Resources ETF
PHO
$1.99B
$1.31K ﹤0.01%
18
PPG icon
236
PPG Industries
PPG
$26.1B
$1.26K ﹤0.01%
12
GEV icon
237
GE Vernova
GEV
$284B
$1.23K ﹤0.01%
2
BTI icon
238
British American Tobacco
BTI
$136B
$1.17K ﹤0.01%
22
VRTS icon
239
Virtus Investment Partners
VRTS
$1.1B
$1.14K ﹤0.01%
6
CBSH icon
240
Commerce Bancshares
CBSH
$8.62B
$1.08K ﹤0.01%
19
CARR icon
241
Carrier Global
CARR
$57B
$1.01K ﹤0.01%
17
DOC icon
242
Healthpeak Properties
DOC
$15.5B
$977 ﹤0.01%
51
TAP icon
243
Molson Coors Class B
TAP
$7.67B
$905 ﹤0.01%
20
BABA icon
244
Alibaba
BABA
$275B
$894 ﹤0.01%
5
GSK icon
245
GSK
GSK
$104B
$872 ﹤0.01%
20
BIIB icon
246
Biogen
BIIB
$30.4B
$840 ﹤0.01%
6
CMA
247
DELISTED
Comerica
CMA
$762 ﹤0.01%
11
OTIS icon
248
Otis Worldwide
OTIS
$28.2B
$731 ﹤0.01%
8
BAX icon
249
Baxter International
BAX
$11.7B
$688 ﹤0.01%
30
TAK icon
250
Takeda Pharmaceutical
TAK
$54.8B
$659 ﹤0.01%
45

Similar funds

Fairman Group's Q3 2025 Portfolio in Review

As of Q3 2025, Fairman Group held 284 positions worth $124M, up 2.1% from $122M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Fairman Group's Q3 2025 filing shows 27 new, 59 increased, 25 reduced and 10 closed positions. Its largest new stake was Diamond Hill Large Cap Concentrated ETF: 91,273 shares worth $1.19M. The largest sale was Essent Group, an estimated $1.46M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

  • Fairman Group's largest Q3 2025 buy was Diamond Hill Large Cap Concentrated ETF: 91,273 shares worth $1.19M.
  • Fairman Group added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $2.18M increase.
  • Fairman Group's biggest Q3 2025 reduction was Essent Group, cutting an estimated $1.46M.
  • Fairman Group fully exited State Street SPDR Portfolio Developed World ex-US ETF in Q3 2025, selling an estimated $75.8K.
  • Fairman Group's ten largest holdings make up 70% of its $124M portfolio in Q3 2025.
  • Fairman Group opened 27 new positions and closed 10 in Q3 2025.
  • Fairman Group's portfolio value rose 2.1% quarter-over-quarter to $124M.

Based on Fairman Group's 13F filing for Q3 2025, filed 31 Oct 2025.